Supporters of Right-To-Try Legislation Sue FDA to Release Documents Related to Ebola Drug Use during Last Year’s Ebola Outbreak

The Goldwater Institute, a think tank lobbying for the expanded access to experimental drugs, commonly known as the Right-To-Try Legislation, sued FDA to disclose the regulatory processes used to release an experimental Ebola drug to a few patients in the US during last year’s Ebola outbreak. In August 2014, FDA allowed use of Zmapp, an … Read more

FDA Mistakenly Widened the Market for a Rare Sleep Disorder Drug: A Consumer Group

In the first quarter of 2014, a drug Hetlioz was approved by the FDA. It’s used to treat non-24 sleep-wake disorder, it’s a rare health condition related to sleeping issues that completely offset the internal body clock. However, according to a consumer advocacy group the agency mistakenly widened the market beyond its anticipated limits. In … Read more